1. Low Lymphocyte Count Is Associated With Radiotherapy Parameters and Affects the Outcomes of Esophageal Squamous Cell Carcinoma Patients
   Xin Wang et al, 2020, Frontiers in Oncology CrossRef
2. Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX
   Pengqin Xu et al, 2021, Frontiers in Oncology CrossRef
3. Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT)
   Lei Wu et al, 2022, Frontiers in Oncology CrossRef
4. Neoadjuvant immunotherapy for resectable esophageal cancer: A review
   Qing Li et al, 2022, Frontiers in Immunology CrossRef
5. Advancements in the research of immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma
   Mengfei Sun, 2024, American Journal of Cancer Research CrossRef